⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Official Title: A Phase 1/2 Study Evaluating the Safety and Efficacy of ABT 751 in Combination With Pemetrexed Versus Pemetrexed Alone in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer

Study ID: NCT00297089

Study Description

Brief Summary: To determine the efficacy of ABT-751 when administered in combination with standard pemetrexed in subjects with advanced or metastatic NSCLC. The Phase 1 portion of the study is complete and the study is currently enrolling subjects in Phase 2.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Site Reference ID/Investigator# 3358, Fayetteville, Arkansas, United States

Site Reference ID/Investigator# 4102, Hot Springs, Arkansas, United States

Site Reference ID/Investigator# 2127, Greenbrae, California, United States

Site Reference ID/Investigator# 2417, Fort Collins, Colorado, United States

Site Reference ID/Investigator# 5690, Torrington, Connecticut, United States

Site Reference ID/Investigator# 2411, Fort Lauderdale, Florida, United States

Site Reference ID/Investigator# 3363, Lakeland, Florida, United States

Site Reference ID/Investigator# 3352, Port St. Lucie, Florida, United States

Site Reference ID/Investigator# 3807, Atlanta, Georgia, United States

Site Reference ID/Investigator# 3353, Chicago, Illinois, United States

Site Reference ID/Investigator# 3359, Indianapolis, Indiana, United States

Site Reference ID/Investigator# 2416, Baltimore, Maryland, United States

Site Reference ID/Investigator# 2244, Baltimore, Maryland, United States

Site Reference ID/Investigator# 2401, Bethesda, Maryland, United States

Site Reference ID/Investigator# 3793, Peabody, Massachusetts, United States

Site Reference ID/Investigator# 3362, Worcester, Massachusetts, United States

Site Reference ID/Investigator# 2075, Kalamazoo, Michigan, United States

Site Reference ID/Investigator# 2418, Jefferson City, Missouri, United States

Site Reference ID/Investigator# 4170, St. Louis, Missouri, United States

Site Reference ID/Investigator# 3357, Lebanon, New Hampshire, United States

Site Reference ID/Investigator# 5098, Lake Success, New York, United States

Site Reference ID/Investigator# 2242, Huntersville, North Carolina, United States

Site Reference ID/Investigator# 2413, Columbus, Ohio, United States

Site Reference ID/Investigator# 3354, Bethelem, Pennsylvania, United States

Site Reference ID/Investigator# 6006, Philadelphia, Pennsylvania, United States

Site Reference ID/Investigator# 2414, Bristol, Tennessee, United States

Site Reference ID/Investigator# 2070, Tacoma, Washington, United States

Site Reference ID/Investigator# 4687, Brno, , Czech Republic

Site Reference ID/Investigator# 3337, Brno, , Czech Republic

Site Reference ID/Investigator# 4278, Kyjov, , Czech Republic

Site Reference ID/Investigator# 3328, Novy Jicin, , Czech Republic

Site Reference ID/Investigator# 3327, Olomouc, , Czech Republic

Site Reference ID/Investigator# 3343, Ostrava-Poruba, , Czech Republic

Site Reference ID/Investigator# 3344, Prague 2, , Czech Republic

Site Reference ID/Investigator# 3342, Prague 4, , Czech Republic

Site Reference ID/Investigator# 3411, Pribram, , Czech Republic

Site Reference ID/Investigator# 3405, Heraklion, , Greece

Site Reference ID/Investigator# 3403, Thessaloniki, , Greece

Site Reference ID/Investigator# 3406, Thessaloniki, , Greece

Site Reference ID/Investigator# 3331, Budapest, , Hungary

Site Reference ID/Investigator# 3333, Miskolc, , Hungary

Site Reference ID/Investigator# 3332, Szekesfehervar, , Hungary

Site Reference ID/Investigator# 3409, Amsterdam, , Netherlands

Site Reference ID/Investigator# 3319, Eindhoven, , Netherlands

Site Reference ID/Investigator# 3341, Haraderwijk, , Netherlands

Site Reference ID/Investigator# 3528, Hoorn, , Netherlands

Site Reference ID/Investigator# 3400, Bratislava, , Slovakia

Site Reference ID/Investigator# 3410, Martin, , Slovakia

Contact Details

Name: Gary Gordon, MD

Affiliation: AbbVie

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: